Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial

Hepato-Gastroenterology

Volumn 46, Issue 27, 1999, Pages 2035-2038

  Lygidakis, N J ^a,b   Sgourakis, G ^a   Aphinives, P ^a  

^a ATHENS MEDICAL CENTER   (Greece)

^b NONE   (Greece)

Author keywords

Adjuvant chemotherapy; Gastric cancer; Hypoxic abdominal chemotherapy; Neo adjuvant chemotherapy; Stop flow perfusion

Indexed keywords

EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGIONAL PERFUSION; STOMACH CARCINOMA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERS, INDWELLING; CELL HYPOXIA; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0032792397     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wisbeck WM, Becheer EM, Russell AH: Adenocarcinoma of the stomach; Autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986; 7:13-18.
2. Heemans J, Bonenkanip JJ, Boon MC, et al: Adjuvant therapy after curative resection for gastric cancer: Meta- analysis of randomized trials. J Clin Oncol 1993; 11:1441-1447.
3. Lise M, Nitti D, Marchet A, et al: Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxo-rubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol 1995; 13(11):2757-2763.
4. Japanese Classification of Gastric Carcinoma, Japanese Research Society for Gastric Cancer: First English Edition. Tokyo: Kanehara & Co., Ltd., 1995.
5. Landry J, Tepper JE, Wood WC, et al: Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990; pp. 1357-1362.
6. Cole WH, Roberts SS, Webb RS, et al: Dissemination of cancer with special emphasis on vascular spread and implantation. Ann Surg 1965; 161:753-770.
7. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look), clinico-pathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1992; 8:1-11.
8. Cunliffe WJ, Sugarbaker PH: Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemo-therapy. Br J Surg 1989; 76:1082-1090.
9. Jacquet P, Stuart OA, Dalton R, et al: Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites. J Surg Onc 1996; 62:128-134.